Member Info for LochinvarLass

My view is not worth a lot here, but there a 180k we know about who succumbed to Covid. Those who are immunsurpressed are ignored altogether in the UK.

I'm not sure if I ever saw whether the targeting of dentritic cells means that Scancell's Covidity vaccine will be a global lifeline for all those around the globe who have no effective vaccine.

My hope is that having worked for decades with thise who are immunsurpressed, led to Scabcell taking a much better path which benefits everyone.

Lack of effective media handling not withstanding, even a proactive session would be something useful to have outdoor public consumption.

In the meantime, I will pick up what I can whilst the share remains ignored by private and institutional investors alike.

All the best everyone, LL

BURBLE, Thanks for this.

21 likes as of now, which is more than I can recall seeing for some time - makes me think I should be sharing the link for this board to help grow the number of those in the know.

This is indeed an exciting time for new solutions, and whilst few firms have 1st claimer advantage (which helps their financial success), I'm quite content knowing that there are others also doing essential research and making major breakthroughs.

I hope all have been enjoying the day, whatever you have been doing with your time.

Burble, thanks for looking into the immunosurpressed immunity situation. There are many who are in this situation. From what little I have been able to find the dentritic cells are not usually targeted by the medications being used to treat serious medical conditions.

Understand the pressures of work. I'd best get back to mine...

Hope you don't mind a daft lassie question about covidity.

Currently many who are immunsurpressed don't benefit from the mRNA vaccines in the way that everyone else does.

Does Scancells covidity vaccine provide some hope? - eg as the dentritic cells it targets are not the ones which are most affected by medical treatment.

Tweets are out now. I search for Scancell and then have to correct Twitter's assumption for Scanell..

Trinity Delta seem to be saying their valuation is around 30p all in.

https://app.researchpool.com/provider/trinity-delta/scancell-holdings-sclp-trinity-delta-lighthouse-scancell-7iNy0C8Kz8?utm_source=dlvr.it&utm_medium=twitter

Trinity Delta Lighthouse: Scancell
Trinity Delta view: The first-in-human trial of Scancell’s Modi-1 vaccine is a key step that could provide important information on the safety and immunogenicity of this novel approach, with the latter providing valuable early indications of potential efficacy. Assuming a smooth roll-out to the other study centres and no recruitment issues, early safety and immunogenicity data should be available by H222, and early efficacy results during 2023. Scancell has four novel inter-related technology platforms: ImmunoBody, Moditope, Glymabs, and AvidiMab. The ImmunoBody and Moditope oncology vaccines offer different approaches to treat intractable cancers both as monotherapy and in combination with agents such as CPIs. We value Scancell using an rNPV model and the Moditope programme is the largest contributor to our 29.1p/share (24.2p fully diluted) valuation, accounting for 11.9p (9.9p fully diluted). Successful clinical outcomes with Modi-1 would validate the Moditope platform and would lead, in our view, to material upside.

I agree, good stuff happening.

I did my bed and Isa a few weeks ago. I am looking forward to thise tax free gains eventually!

Covid during pregnancy doubled babies’ risk of delayed development in speech, motor skills

This crossed my covid feed - apologies if it has already been discussed witht he need for better covid vaccines.

https://www.scmp.com/news/world/united-states-canada/article/3181102/covid-during-pregnancy-doubled-babies-risk-delayed

Hi all, I just want to thank everyone for their contributions- it was great to wake up to such a stimulating discussion which has expanded my knowledge considerably in a very easily understandable way.

Time to get out for a walk - it's taking longer than I expected for the ankle to heal, so it won't be far or quick. I have found going slower gives more time to appreciate more things.

Finding joy in the day, LL

JB, and everyone else,

Thanks for following up on this.

I got a random US Biotech investor type connection on one of the social media channels so I could not resist mentioning Scancell. With the drop in the £, Scancell looking like a bargain!

Wow Cleaner, the BMJ saying what I've felt for 2 years.

New Zealand, Cyprus, and Luxembourg have all now passed over 1,000 officials deaths attributed to Covid 19. Over 6m around the globe now.

I know several people who have had covid more than once, and each time it eroded their household incomes.

Or perhaps, Don't Look Up..

RR, Feels more like 2001: A Space Odyssey to me.

Scancell may not be posting on Twitter, but Marcus is... https://twitter.com/mwl471/status/1526671043070464002?s=20&t=jlpmzyD8Eec4b8IANBcLjg

The account makes excellent points. It us a pity that there isn't any ampliflification.

Burble, I was quite happy to be wrong in estimating too late. I never imagined my guess would be far too early for FPD news.

Surely by now the FPD event must have happened, given there are 20 centres. . . If we are waiting for more substantive data, perhaps we need another sweep.

Thanks for your thoughts. As you say, the data from the trials is a key driver.

At one point there was speculation about the minimum price of a RM takeover. I was merely asking if that should happen, would the price be north of 20p rather than around 13p.

Like others, I'm keen for the tech Scancell has developed be evaluated through the trials. Obviously, I hope that those who would benefit will have better options as a result of the the extensive work Scancell has done.

So, am I being too simplistic in thinking ingredients that Durrant wooed RedMile, who if they had to buy on the open market, would have sent the price skyward?

Also, should they want to take over the company, the price would need to be at this price, and not the 13.x p point?

With day traders exiting at 14p, hopefully the share price will stay well above the 11p entry point for a while - I hope they find better targets.

And recovered about 20% already :)

Thanks all for these comments. I take Burbles points on timing, and feel that if there was wider knowledge of the CT that the recruitment would be a runaway success. Like others here, I believe this is a real prospect for a much more robust outcome in quality of life as well as longevity.

Being on my first holiday since before the 1st lockdown, my biggest fear is that I will arrive home with covid for the first time. I will happily volunteer when the UK arm of CT1 is underway, providing I fit the demographics required

Good question Bermuda

The deafening lack of news, solutions, and take up ( or takeover )of approved solutions as the preferred way forward has lead me to think they want to milk the cash cows a bit longer - perhaps building the coffers to cope with a less funding being announced for multi / universal covid vaccines.